John A. Ward

Array ( [id] => 7216179 [patent_doc_number] => 20040071674 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Therapeutic treatment of digestive organs with engineered stem cells' [patent_app_type] => new [patent_app_number] => 10/392377 [patent_app_country] => US [patent_app_date] => 2003-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7214 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20040071674.pdf [firstpage_image] =>[orig_patent_app_number] => 10392377 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6730723 [patent_doc_number] => 20030186913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Expression of exogenous polynucleotide sequences in a vertebrate' [patent_app_type] => new [patent_app_number] => 10/360645 [patent_app_country] => US [patent_app_date] => 2003-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 29042 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20030186913.pdf [firstpage_image] =>[orig_patent_app_number] => 10360645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7216164 [patent_doc_number] => 20040071673 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease' [patent_app_type] => new [patent_app_number] => 10/359397 [patent_app_country] => US [patent_app_date] => 2003-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 7553 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20040071673.pdf [firstpage_image] =>[orig_patent_app_number] => 10359397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6701091 [patent_doc_number] => 20030223971 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectors' [patent_app_type] => new [patent_app_number] => 10/342088 [patent_app_country] => US [patent_app_date] => 2003-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19831 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20030223971.pdf [firstpage_image] =>[orig_patent_app_number] => 10342088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6703277 [patent_doc_number] => 20030226157 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Graft animal model for high induction of papillomas, the propagation of papillomavirus and evaluation of candidate therapeutic agents' [patent_app_type] => new [patent_app_number] => 10/331395 [patent_app_country] => US [patent_app_date] => 2002-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 11883 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20030226157.pdf [firstpage_image] =>[orig_patent_app_number] => 10331395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5715174 [patent_doc_number] => 20060078537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-13 [patent_title] => 'Mono-and dual chemokine/cytokine constructs' [patent_app_type] => utility [patent_app_number] => 10/499151 [patent_app_country] => US [patent_app_date] => 2002-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 21064 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20060078537.pdf [firstpage_image] =>[orig_patent_app_number] => 10499151 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5693673 [patent_doc_number] => 20060153820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Materials and methods relating to the production and maintenance of cell lines' [patent_app_type] => utility [patent_app_number] => 10/499242 [patent_app_country] => US [patent_app_date] => 2002-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11802 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20060153820.pdf [firstpage_image] =>[orig_patent_app_number] => 10499242 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7378729 [patent_doc_number] => 20040028651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-12 [patent_title] => 'Composition and methods of using hiv vpr' [patent_app_type] => new [patent_app_number] => 10/311260 [patent_app_country] => US [patent_app_date] => 2002-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 15258 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20040028651.pdf [firstpage_image] =>[orig_patent_app_number] => 10311260 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6639318 [patent_doc_number] => 20030212025 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Cd154 variants' [patent_app_type] => new [patent_app_number] => 10/297452 [patent_app_country] => US [patent_app_date] => 2002-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6927 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20030212025.pdf [firstpage_image] =>[orig_patent_app_number] => 10297452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5596257 [patent_doc_number] => 20060160174 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Modified l49-sfv exhibiting increased stability and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 10/537143 [patent_app_country] => US [patent_app_date] => 2002-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18370 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20060160174.pdf [firstpage_image] =>[orig_patent_app_number] => 10537143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 591443 [patent_doc_number] => 07435871 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-14 [patent_title] => 'Transgenic animals bearing human Igλ light chain genes' [patent_app_type] => utility [patent_app_number] => 10/307231 [patent_app_country] => US [patent_app_date] => 2002-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 12 [patent_no_of_words] => 22465 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/435/07435871.pdf [firstpage_image] =>[orig_patent_app_number] => 10307231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4644271 [patent_doc_number] => 08021876 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-20 [patent_title] => 'Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof' [patent_app_type] => utility [patent_app_number] => 10/495419 [patent_app_country] => US [patent_app_date] => 2002-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 6 [patent_no_of_words] => 16845 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/021/08021876.pdf [firstpage_image] =>[orig_patent_app_number] => 10495419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6791562 [patent_doc_number] => 20030086906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-08 [patent_title] => 'Method of inducing an immune response using vaccinia virus recombinants' [patent_app_type] => new [patent_app_number] => 10/288663 [patent_app_country] => US [patent_app_date] => 2002-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5015 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20030086906.pdf [firstpage_image] =>[orig_patent_app_number] => 10288663 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6685204 [patent_doc_number] => 20030121068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Vector encoding suicide and marker constructs' [patent_app_type] => new [patent_app_number] => 10/288250 [patent_app_country] => US [patent_app_date] => 2002-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15309 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20030121068.pdf [firstpage_image] =>[orig_patent_app_number] => 10288250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6818243 [patent_doc_number] => 20030069201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-10 [patent_title] => 'Methods of using BCL-2 for the therapeutic treatment and prevention of diseases' [patent_app_type] => new [patent_app_number] => 10/285853 [patent_app_country] => US [patent_app_date] => 2002-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 14063 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20030069201.pdf [firstpage_image] =>[orig_patent_app_number] => 10285853 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 390472 [patent_doc_number] => 07301068 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-11-27 [patent_title] => 'Nonhuman model animal of Th2-mediated hyperimmune response' [patent_app_type] => utility [patent_app_number] => 10/493835 [patent_app_country] => US [patent_app_date] => 2002-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9655 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/301/07301068.pdf [firstpage_image] =>[orig_patent_app_number] => 10493835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6674841 [patent_doc_number] => 20030060444 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-27 [patent_title] => 'Cell activation process and reagents therefor' [patent_app_type] => new [patent_app_number] => 10/280596 [patent_app_country] => US [patent_app_date] => 2002-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 6165 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20030060444.pdf [firstpage_image] =>[orig_patent_app_number] => 10280596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6696330 [patent_doc_number] => 20030108524 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Vectors for expressing multiple transgenes' [patent_app_type] => new [patent_app_number] => 10/273346 [patent_app_country] => US [patent_app_date] => 2002-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 25374 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20030108524.pdf [firstpage_image] =>[orig_patent_app_number] => 10273346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7679163 [patent_doc_number] => 20030167489 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Targeted replacement of a gene without endogenous and selectable residual sequences' [patent_app_type] => new [patent_app_number] => 10/272358 [patent_app_country] => US [patent_app_date] => 2002-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7738 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20030167489.pdf [firstpage_image] =>[orig_patent_app_number] => 10272358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7199971 [patent_doc_number] => 20050042202 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Compositions for and methods of treating and preventing sirs/sepsis' [patent_app_type] => utility [patent_app_number] => 10/491800 [patent_app_country] => US [patent_app_date] => 2002-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9710 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20050042202.pdf [firstpage_image] =>[orig_patent_app_number] => 10491800 [rel_patent_id] =>[rel_patent_doc_number] =>)